{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:51:39Z","timestamp":1791449499727,"version":"4.3.3"},"reference-count":136,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/17512433.2026.2737765","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:57:59Z","timestamp":1790078279000},"page":"837-854","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Theranostics in the management of prostate cancer: from concept to clinical practice"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-6503","authenticated-orcid":false,"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[{"name":"Arabian Gulf University","place":["Manama, Bahrain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Alonso-Gordoa","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowri","family":"Sivaramakrishnan","sequence":"additional","affiliation":[{"name":"Bahrain Defence Force Royal Medical Services","place":["Riffa, Bahrain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Molina","family":"Cerrillo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ram\u00f3n y Cajal","place":["Madrid, Spain"]},{"name":"ARON Research Foundation ETS","place":["Macerata, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Fiala","sequence":"additional","affiliation":[{"name":"ARON Research Foundation ETS","place":["Macerata, Italy"]},{"name":"Faculty of Medicine and University Hospital Pilsen, Charles University","place":["Pilsen, Czechia"]},{"name":"Charles University","place":["Pilsen, Czechia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Rehan","sequence":"additional","affiliation":[{"name":"Queens University","place":["Belfast, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Mena Cortes","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n UroTeragLATAM","place":["Sonora, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Santoni","sequence":"additional","affiliation":[{"name":"ARON Research Foundation ETS","place":["Macerata, Italy"]},{"name":"Macerata Hospital","place":["Macerata, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1553747"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.11.013"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83840-3"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2023038"},{"key":"e_1_3_5_7_1","unstructured":"Rosario E Rosario DJ. Localized prostate cancer. [Updated 2022 Sep 26]. In: StatPearls [internet]. Treasure Island FL: StatPearls Publishing; 2025 Jan-. [2025 Nov 9]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563248\/"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-018-0079-0"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030689"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205047"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-024-01215-2"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00007"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.6_suppl.64"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-024-01410-w"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60654-z"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00652-y"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30821-6"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2016.11.002"},{"issue":"9","key":"e_1_3_5_19_1","first-page":"407","article-title":"Folate hydrolase assay and binding studies of PC3 cells transfected with mutant prostate specific membrane antigen","volume":"67","author":"Wang X","year":"2007","unstructured":"Wang X, Heston W. Folate hydrolase assay and binding studies of PC3 cells transfected with mutant prostate specific membrane antigen. Cancer Res. 2007;67(9_Sup plement):407.","journal-title":"Cancer Res"},{"issue":"6","key":"e_1_3_5_20_1","first-page":"605","article-title":"Jejunal brush-border folate hydrolase. A novel enzyme","volume":"155","author":"Halsted CH","year":"1991","unstructured":"Halsted CH. Jejunal brush-border folate hydrolase. A novel enzyme. West J Med. 1991;155(6):605.","journal-title":"West J Med"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12857"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.279.6.C1889"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21065"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0544-5"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.06.030"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.11.012"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2012.04.016"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101292"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060906"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.257238"},{"key":"e_1_3_5_31_1","volume-title":"Presented at: 41st Annual Congress of the European Association of Urology","author":"Buteau JP","year":"2026","unstructured":"Buteau JP, Moon D, Fahey MT, et al. Impact of [68Ga]Ga-PSMA-11 PET\/CT in the diagnosis of prostate cancer in men with equivocal or non-suspicious findings on multi-parametric MRI (PRIMARY2): a multi-centre, phase iii, randomised trial. In: Presented at: 41st Annual Congress of the European Association of Urology; London, (UK); 2026 Mar 13\u201316."},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.226381"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102738"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-022-00544-3"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2949-6"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2017.02.006"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193359"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04385-6"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.01.049"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30314-7"},{"key":"e_1_3_5_42_1","first-page":"1630","article-title":"Lutetium-177 PSMA radionuclide therapy for men with prostate cancer","volume":"58","author":"Emmett L","year":"2017","unstructured":"Emmett L, Willowson K, Violet J, et al. Lutetium-177 PSMA radionuclide therapy for men with prostate cancer. J Nucl Med. 2017;58:1630\u20131636.","journal-title":"J Nucl Med"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178673"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4167-0"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00332-8"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.115831"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06089-w"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0096"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.07.003"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(26)01092-5"},{"key":"e_1_3_5_52_1","unstructured":"U.S. Food and Drug Administration. FDA expands Pluvicto\u2019s metastatic castration-resistant prostate cancer indication. 2025. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-expands-pluvictos-metastatic-castration-resistant-prostate-cancer-indication"},{"key":"e_1_3_5_53_1","unstructured":"Oncology News Central. Treatment guide for 177Lu-PSMA-617 (pluvicto). 2025. Available from: https:\/\/www.oncologynewscentral.com\/drugs\/guide\/177-lu-psma-617-prostate-cancer"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06255-8"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219352"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.47251"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265952"},{"key":"e_1_3_5_58_1","unstructured":"European Association of Urology. EAU guidelines on prostate cancer: treatment. 2025. Available from: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/treatment"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2018.09.014"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268363"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.239006"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04485-3"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171397"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.183194"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7245"},{"key":"e_1_3_5_66_1","first-page":"97","article-title":"177Lu-PSMA-617 in salvage therapy: safety and biochemical efficacy","volume":"36","author":"Ahmadzadehfar H","year":"2015","unstructured":"Ahmadzadehfar H, Azgomi M, Hauser S, et al. 177Lu-PSMA-617 in salvage therapy: safety and biochemical efficacy. Nucl Med Commun. 2015;36:97\u2013104.","journal-title":"Nucl Med Commun"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30198-0"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00529-6"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01653-2"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.08.026"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2016.13"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0226"},{"issue":"4","key":"e_1_3_5_73_1","first-page":"273","article-title":"Neuroendocrine differentiation of prostate cancer: a review","volume":"2","author":"Parimi V","year":"2014","unstructured":"Parimi V, Goyal R, Poropatich K, et al. Neuroendocrine differentiation of prostate cancer: a review. Am J Clin Exp Urol. 2014;2(4):273\u2013285. PMID: 25606573; PMCID: PMC4297323.","journal-title":"Am J Clin Exp Urol"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4045"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah4199"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178228"},{"key":"e_1_3_5_77_1","first-page":"123","article-title":"Clinical significance of DNA repair gene mutations in metastatic prostate cancer","volume":"25","author":"Schweizer MT","year":"2019","unstructured":"Schweizer MT, Zhou XC, Wang H, et al. Clinical significance of DNA repair gene mutations in metastatic prostate cancer. Clin Cancer Res. 2019;25:123\u2013130.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_5_78_1","first-page":"325","article-title":"CDK12-altered prostate cancer: phenotypic and clinical associations","volume":"36","author":"Antonarakis ES","year":"2018","unstructured":"Antonarakis ES, Lu C, Luber B, et al. CDK12-altered prostate cancer: phenotypic and clinical associations. J Clin Oncol. 2018;36:325\u2013335.","journal-title":"J Clin Oncol"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-026-03659-w"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-026-08092-x"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(96)00184-7"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.181800"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.223099"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.5005"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(26)00017-3"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00451-5"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.11.013"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00670-6"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29246062"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00805-7"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.07.027"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gez007"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.240080"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2020.07.005"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-165859"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmrs.227"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286808"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000005968"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270316"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.TPS294"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102748"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2024.10.014"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00638-1"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2025.102452"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000002078"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-026-07893-4"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2025qmarcz30"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103101"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07103-7"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.07.1326"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.127"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01653-2"},{"key":"e_1_3_5_113_1","unstructured":"Lantheus. Study evaluating metastatic castrate resistant prostate cancer treatment with [Lu-177]-PNT2002 (SPLASH). ClinicalTrials.gov identifier: NCT04647526."},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23154"},{"issue":"1","key":"e_1_3_5_115_1","first-page":"S1300","article-title":"LuPARP: phase I trial of [177Lu]Lu-PSMA-617 and olaparib in patients with metastatic castration-resistant prostate cancer","volume":"36","author":"Sandhu SK","year":"2025","unstructured":"Sandhu SK, Joshua AM, Emmett L, et al. LuPARP: phase I trial of [177Lu]Lu-PSMA-617 and olaparib in patients with metastatic castration-resistant prostate cancer. Ann Oncol. 2025;36(Suppl 1):S1300\u20131301.","journal-title":"Ann Oncol"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00009-9"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-026-07901-7"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13540-9"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2025.07.005"},{"key":"e_1_3_5_120_1","volume-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Limited update March 2025","author":"European Association of Urology","year":"2025","unstructured":"European Association of Urology. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Limited update March 2025. Arnhem: EAU; 2025."},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom15050625"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2308"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.96403"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02501-9"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262186"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043400"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178889"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2022.2145187"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.650249"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198192"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2015.645"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010436"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10214909"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1419"},{"key":"e_1_3_5_135_1","first-page":"211","article-title":"68Ga\u2011DOTATOC PET in prostate cancer with neuroendocrine differentiation","volume":"42","author":"Kroiss A","year":"2015","unstructured":"Kroiss A, Putzer D, Decristoforo C, et al. 68Ga\u2011DOTATOC PET in prostate cancer with neuroendocrine differentiation. Eur J Nucl Med Mol Imag. 2015;42:211\u2013219.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.230607"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002824"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02041-6"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2026.2737765","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17512433.2026.2737765","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2026.2737765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:13:15Z","timestamp":1791447195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2026.2737765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":136,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/17512433.2026.2737765"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2026.2737765","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}